Robotic partial nephrectomy offers similar oncologic outcomes to robotic radical nephrectomy, but is associated with better preservation of renal function.
In a study, all men who received testosterone replacement therapy within 1 year of robot-assisted radical prostatectomy had full potency recovery at 24 months.
Testosterone replacement therapy prolonged time to disease progression among men who underwent radical surgery for localized prostate cancer.
Kidney stone recurrence risk increases along with the number of metabolic syndrome components, which include abdominal obesity, hypertension, elevated fasting glucose, low high-density lipoprotein, and elevated triglycerides.
A phase 2 study demonstrated higher rates of pathologic complete response or minimal residual disease.
A population-based study found no effect of low-dose aspirin use within 1 year of diagnosis on prostate cancer death risk.
Overweight and obesity, compared with normal weight, in adolescence are associated with a 1.8- and 2.9-fold increased risk of renal cell carcinoma later in life, respectively, a study found.
Time from definitive therapy for localized prostate cancer to the start of androgen deprivation therapy (ADT) independently predicts the risk of metastatic castration-resistant prostate cancer (mCRPC) and death, a new study suggests. The study, led by Neeraj Agarwal, MD, of the Huntsman Cancer Institute at the University of Utah in Salt Lake City, included 253…
Higher circulating concentrations of 25-hydroxyvitamin D are associated with a lower risk of renal cell carcinoma (RCC), new data suggest. The data are from a study in which investigators in China compared 135 newly diagnosed cases of RCC with 135 controls matched by age and sex. Average plasma levels of 25-hydroxyvitamin D [25 (OH) D]…
Almost one quarter of men who have a single negative prostate biopsy are eventually diagnosed with prostate cancer (PCa) within 20 years, according to investigators. The finding is from a study of 95,675 men who had a negative first transrectal ultrasound (TRUS)-guided prostate biopsy from January 1994 to October 2014. The 5-, 10-, 15, and…